Survival after Liver Resection for Metastatic Colorectal Carcinoma in a Large Population

Journal of the American College of Surgeons

Volumn 205, Issue 5, 2007, Pages 676-683

  Shah, Shimul A ^a,b   Bromberg, Rudy ^b   Coates, Angela ^c   Rempel, Eddy ^c   Simunovic, Marko ^c   Gallinger, Steven ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; LOBECTOMY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; TEACHING HOSPITAL;

COLORECTAL NEOPLASMS; DATABASES AS TOPIC; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ONTARIO; PROGNOSIS; REGISTRIES; SURVIVAL ANALYSIS;

EID: 35349010496     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2007.06.283     Document Type: Article

References (45)

1. Scheele J., Stangl R., and Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77 (1990) 1241-1246
2. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818-825
3. Shah S.A., Haddad R., Al Sukhni W., et al. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 202 (2006) 468-475
4. Fong Y., Fortner J., Sun R.L., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318
5. Wei A.C., Greig P.D., Grant D., et al. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 13 (2006) 668-676
6. Jarnagin W.R., Gonen M., Fong Y., et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236 (2002) 397-406
7. Abdalla E.K., and Vauthey J.N. Improved survival after resection of colorectal liver metastases. J Clin Oncol 24 (2006) 2679-2681
8. Aloia T.A., Vauthey J.N., Loyer E.M., et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141 (2006) 460-466
9. Choti M.A., Sitzmann J.V., Tiburi M.F., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 (2002) 759-766
10. Pawlik T.M., Scoggins C.R., Zorzi D., et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241 (2005) 715-722
11. Dimick J.B., Wainess R.M., Cowan J.A., et al. National trends in the use and outcomes of hepatic resection. J Am Coll Surg 199 (2004) 31-38
12. Alley P.G., and McNee R.K. Colorectal cancer in Auckland 1981-1982: patients with liver metastases. N Z Med J 98 (1985) 697-699
13. Jaeck D., Bachellier P., Guiguet M., et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 84 (1997) 977-980
14. Leporrier J., Maurel J., Chiche L., et al. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93 (2006) 465-474
15. Kune G.A., Kune S., Field B., et al. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study. Dis Colon Rectum 33 (1990) 938-946
16. Cummings L.C., Payes J.D., and Cooper G.S. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer 109 (2007) 718-726
17. Dimick J.B., Cowan Jr. J.A., Knol J.A., et al. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 138 (2003) 185-191
18. Glasgow R.E., Showstack J.A., Katz P.P., et al. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg 134 (1999) 30-35
19. Fong Y., Gonen M., Rubin D., et al. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 242 (2005) 540-544
20. Choti M.A., Bowman H.M., Pitt H.A., et al. Should hepatic resections be performed at high-volume referral centers?. J Gastrointest Surg 2 (1998) 11-20
21. Dimick J.B., Staiger D.O., and Birkmeyer J.D. Are mortality rates for different operations related?: implications for measuring the quality of noncardiac surgery. Med Care 44 (2006) 774-778
22. Birkmeyer J.D., Sun Y., Goldfaden A., et al. Volume and process of care in high-risk cancer surgery. Cancer 106 (2006) 2476-2481
23. Bentrem D.J., and Brennan M.F. Outcomes in oncologic surgery: does volume make a difference?. World J Surg 29 (2005) 1210-1216
24. Simunovic M., Rempel E., Theriault M.E., et al. Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. Can J Surg 49 (2006) 251-258
25. Fong Y., Gonen M., Rubin D., et al. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 242 (2005) 540-544
26. Roohan P.J., Bickell N.A., Baptiste M.S., et al. Hospital volume differences and five-year survival from breast cancer. Am J Public Health 88 (1998) 454-457
27. Schrag D., Cramer L.D., Bach P.B., et al. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA 284 (2000) 3028-3035
28. Bach P.B., Cramer L.D., Schrag D., et al. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med 345 (2001) 181-188
29. Robles S.C., Marrett L.D., Clarke E.A., et al. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol 41 (1988) 495-501
30. Simunovic M., To T., and Langer B. Influence of hospital volume on mortality following major cancer surgery. JAMA 281 (1999) 1374-1375
31. Cady B., Jenkins R.L., Steele Jr. G.D., et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 227 (1998) 566-571
32. Cady B., Stone M.D., McDermott Jr. W.V., et al. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 127 (1992) 561-568
33. Cady B., and McDermott W.V. Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 201 (1985) 204-209
34. Hong D., Tandan V.R., Goldsmith C.H., et al. Users' guide to the surgical literature: how to use an article reporting population-based volume-outcome relationships in surgery. Can J Surg 45 (2002) 109-115
35. Langer B., and Stern H. An integrated system-wide strategy for quality improvement in cancer surgery. Br J Surg 94 (2007) 3-5
36. Simunovic M., To T., Theriault M., et al. Relation between hospital surgical volume and outcome for pancreatic resection for neoplasm in a publicly funded health care system. CMAJ 160 (1999) 643-648
37. Birkmeyer J.D., Siewers A.E., Finlayson E.V., et al. Hospital volume and surgical mortality in the United States. N Engl J Med 346 (2002) 1128-1137
38. Birkmeyer J.D., Siewers A.E., Marth N.J., et al. Regionalization of high-risk surgery and implications for patient travel times. JAMA 290 (2003) 2703-2708
39. Hughes K.S., Simon R., Songhorabodi S., et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 100 (1986) 278-284
40. Hamady Z.Z., Cameron I.C., Wyatt J., et al. Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule. Eur J Surg Oncol 32 (2006) 557-563
41. Saltz L.B., Meropol N.J., Loehrer Sr. P.J., et al. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol 22 (2004) 1201-1208
42. Bilchik A.J., Poston G., Curley S.A., et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 23 (2005) 9073-9078
43. Abdalla E.K., Eng C., Madary A., et al. Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. Clin Colorectal Cancer 5 (2006) 436-439
44. Fong Y., and Bentrem D.J. CASH (Chemotherapy-Associated Steatohepatitis) costs. Ann Surg 243 (2006) 8-9
45. Abdalla E.K., Adam R., Bilchik A.J., et al. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13 (2006) 1271-1280